IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN.
Saved in:
| Title: | IMMUNOCHEMOTHERAPY WITH OBINUTUZUMAB OR RITUXIMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA IN THE RANDOMISED PHASE III GALLIUM STUDY: ANALYSIS BY CHEMOTHERAPY REGIMEN. |
|---|---|
| Authors: | Hiddemann, W., Barbui, A.M., Canales Albendea, M.A., Cannell, P.K., Collins, G.P., Dürig, J., Forstpointner, R., Herold, M., Hertzberg, M., Klanova, M., Radford, J.A., Tobinai, K., Burciu, A., Fingerle ‐ Rowson, G.R., Nielsen, T., Wolbers, M., Marcus, R. |
| Source: | Hematological oncology Jun2017 Supplement; Vol. 35. |
| Journal Info: | Publisher: Wiley-Blackwell ISSN: 0278-0232 |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
